Literature DB >> 23376447

C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care.

Paul M Ridker1, John J P Kastelein, Jacques Genest, Wolfgang Koenig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23376447     DOI： 10.1093/eurheartj/eht022

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  13 in total

Review 1.  Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?

Authors:  Johannes Mair; Allan S Jaffe
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

2.  Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

Authors:  Herbert I Hurwitz; Nikhil Uppal; Stephanie A Wagner; Johanna C Bendell; J Thaddeus Beck; Seaborn M Wade; John J Nemunaitis; Philip J Stella; J Marc Pipas; Zev A Wainberg; Robert Manges; William M Garrett; Deborah S Hunter; Jason Clark; Lance Leopold; Victor Sandor; Richard S Levy
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 3.  Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.

Authors:  Michael A Gimbrone; Guillermo García-Cardeña
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  Gender and the active smoking and high-sensitivity C-reactive protein relation in late adolescence.

Authors:  Chi Le-Ha; Lawrence J Beilin; Sally Burrows; Wendy H Oddy; Beth Hands; Trevor A Mori
Journal:  J Lipid Res       Date:  2014-02-27       Impact factor: 5.922

5.  The Effects of Job Instability and Financial Strain on C-Reactive Protein in a Sample of Mexican Immigrants.

Authors:  Patrick R Steffen; Jill Walker; Richard Meredith; Chris Anderson
Journal:  Ethn Dis       Date:  2016-01-21       Impact factor: 1.847

Review 6.  C-reactive protein: clinical and epidemiological perspectives.

Authors:  Juan Salazar; María Sofía Martínez; Mervin Chávez; Alexandra Toledo; Roberto Añez; Yaquelín Torres; Vanessa Apruzzese; Carlos Silva; Joselyn Rojas; Valmore Bermúdez
Journal:  Cardiol Res Pract       Date:  2014-02-06       Impact factor: 1.866

Review 7.  High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities.

Authors:  Francisco Antonio Helfenstein Fonseca; Maria Cristina de Oliveira Izar
Journal:  Clinics (Sao Paulo)       Date:  2016-04       Impact factor: 2.365

Review 8.  Pentraxins: structure, function, and role in inflammation.

Authors:  Terry W Du Clos
Journal:  ISRN Inflamm       Date:  2013-09-14

9.  Coronary Plaque Characteristics Assessed by 256-Slice Coronary CT Angiography and Association with High-Sensitivity C-Reactive Protein in Symptomatic Patients with Type 2 Diabetes.

Authors:  Jinling Zhang; Zhehao Lv; Deli Zhao; Lili Liu; Yong Wan; Tingting Fan; Huimin Li; Ying Guan; Bailu Liu; Qi Yang
Journal:  J Diabetes Res       Date:  2016-08-08       Impact factor: 4.011

10.  The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.

Authors:  Jinglin Mo; Zimo Chen; Jie Xu; Anxin Wang; Xia Meng; Xingquan Zhao; Hao Li; Shouling Wu; Yongjun Wang
Journal:  Aging (Albany NY)       Date:  2020-06-16       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.